Hepatic metastases resection after cetuximab: are we missing something? - Authors' reply
Lancet Oncol
.
2020 May;21(5):e229.
doi: 10.1016/S1470-2045(20)30239-4.
Authors
Sian A Pugh
1
,
John A Bridgewater
2
,
John N Primrose
3
;
New EPOC investigators
Affiliations
1
Addenbrookes Hospital, Cambridge, UK.
2
UCL Cancer Institute, University College London, London, UK.
3
Department of Surgery, University of Southampton, Southampton SO16 6YD, UK. Electronic address: silverio.J.N.Primrose@soton.ac.uk.
PMID:
32359494
DOI:
10.1016/S1470-2045(20)30239-4
No abstract available
Publication types
Letter
Comment
MeSH terms
Cetuximab
Colorectal Neoplasms*
Hepatectomy
Humans
Liver Neoplasms / surgery*
Substances
Cetuximab
Grants and funding
10549/CRUK_/Cancer Research UK/United Kingdom
7275/CRUK_/Cancer Research UK/United Kingdom